Lara Longpre - CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Issuer Symbol
MIRM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lara Longpre since 28 Jan 2025

Holdings reported by Lara Longpre for Mirum Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 104,407 $2,734,607 $26.19 02 Feb 2024 Direct
Restricted Stock Units 8,000 $224,281 $28.04 23 Jan 2024 Direct Common Stock
Stock Option (right to buy) 32,000 23 Jan 2024 Direct Common Stock

Transactions reported by Lara Longpre for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.